Works matching DE "FLUOROPYRIMIDINES"

Results: 522

Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 753, doi. 10.1007/s00280-011-1761-2

By:

Scheulen, Max;
Saito, Kaku;
Hilger, Ralf;
Mende, Bastian;
Zergebel, Christopher;
Strumberg, Dirk

Publication type:

Article

Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 439, doi. 10.1007/s00280-011-1723-8

By:

Satoh, Taroh;
Yamada, Yasuhide;
Muro, Kei;
Hayashi, Hidetoshi;
Shimada, Yasuhiro;
Takahari, Daisuke;
Taku, Keisei;
Nakajima, Takako;
Shi, Xiaojin;
Brown, Kathryn;
Boku, Narikazu

Publication type:

Article

Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1565, doi. 10.1007/s00280-011-1639-3

By:

Saif, Muhammad;
Sarantopoulos, John;
Patnaik, Amita;
Tolcher, Anthony;
Takimoto, Chris;
Beeram, Murali

Publication type:

Article

Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1355, doi. 10.1007/s00280-011-1709-6

By:

Giorgio, E.;
Caroti, C.;
Mattioli, F.;
Uliana, V.;
Parodi, M.;
D'Amico, Mauro;
Fucile, C.;
Marini, V.;
Forzano, F.;
Cassola, G.;
Martelli, A.;
Faravelli, F.;
Di Maria, E.

Publication type:

Article

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1323, doi. 10.1007/s00280-010-1425-7

By:

Hong, Junshik;
Han, Sae-Won;
Ham, Hye;
Kim, Tae-Yong;
Choi, In;
Kim, Byung-Su;
Oh, Do-Youn;
Im, Seock-Ah;
Kang, Gyeong;
Bang, Yung-Jue;
Kim, Tae-You

Publication type:

Article

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 791, doi. 10.1007/s00280-010-1382-1

By:

Oki, Yasunari;
Hirose, Takashi;
Yamaoka, Toshimitsu;
Kusumoto, Sojiro;
Shirai, Takao;
Sugiyama, Tomohide;
Okuda, Kentaro;
Nakashima, Masanao;
Murata, Yasunori;
Ohmori, Tohru;
Adachi, Mitsuru

Publication type:

Article

DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 49, doi. 10.1007/s00280-010-1282-4

By:

Yang, Chen;
Ciccolini, Joseph;
Blesius, Aurore;
Dahan, Laetitia;
Bagarry-Liegey, Danielle;
Brunet, Caroline;
Varoquaux, Arthur;
Frances, Nicolas;
Marouani, Hafedh;
Giovanni, Antoine;
Ferri-Dessens, Rose-Marie;
Chefrour, Mohamed;
Favre, Roger;
Duffaud, Florence;
Seitz, Jean-François;
Zanaret, Michel;
Lacarelle, Bruno;
Mercier, Cédric

Publication type:

Article

Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 147, doi. 10.1007/s00280-010-1301-5

By:

Bao, Han;
Fang, Wei;
Zhang, Xiao;
Shi, Gen;
Huang, Sui;
Yu, Lan;
Chen, Jin;
Mou, Hai;
Deng, Jing;
Shen, Peng;
Xu, Nong

Publication type:

Article

Increased anticoagulant activity of warfarin used in combination with doxifluridine.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 969, doi. 10.1007/s00280-010-1249-5

By:

Nakajima, Masaru;
Genda, Tomoo;
Suehira, Mayu;
Satoh, Hiroki;
Miki, Akiko;
Hori, Satoko;
Sawada, Yasufumi

Publication type:

Article

A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 871, doi. 10.1007/s00280-009-1092-8

By:

Rocca, Andrea;
Maltoni, Roberta;
Passardi, Alessandro;
Massa, Ilaria;
Aquilina, Michele;
Ridolfi, Ruggero;
Ibrahim, Toni;
Cecconetto, Lorenzo;
Sarti, Samanta;
Pietri, Elisabetta;
Nanni, Oriana;
Amadori, Dino

Publication type:

Article

Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 661, doi. 10.1007/s00280-009-1071-0

By:

Fidlerova, Julie;
Kleiblova, Petra;
Bilek, Matej;
Kormunda, Stanislav;
Formankova, Zuzana;
Novotny, Jan;
Kleibl, Zdenek

Publication type:

Article

The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 403, doi. 10.1007/s00280-009-1147-x

By:

Loganayagam, Aathavan;
Arenas-Hernandez, Monica;
Fairbanks, Lynette;
Ross, Paul;
Sanderson, Jeremy D.;
Marinaki, Anthony M.

Publication type:

Article

K-ras status in squamous cell anal carcinoma (SCC): it’s time for target-oriented treatment?

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 197, doi. 10.1007/s00280-009-1117-3

By:

Zampino, Maria Giulia;
Magni, Elena;
Sonzogni, Angelica;
Renne, Giuseppe

Publication type:

Article

Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase ( DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 3, p. 615, doi. 10.1007/s00280-009-0970-4

By:

Ticha, Ivana;
Kleiblova, Petra;
Fidlerova, Julie;
Novotny, Jan;
Pohlreich, Petr;
Kleibl, Zdenek

Publication type:

Article

The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 911, doi. 10.1007/s00280-008-0815-6

By:

Huang, Zhao-Hui;
Hua, Dong;
Li, Li-Hua

Publication type:

Article

Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 529, doi. 10.1007/s00280-008-0822-7

By:

Yoon Jae Kim;
Seungmin Bang;
Jeong Youp Park;
Seung Woo Park;
Jae Bock Chung;
Si Young Song

Publication type:

Article

High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 63, n. 1, p. 85, doi. 10.1007/s00280-008-0714-x

By:

Kuramochi, Hidekazu;
Hayashi, Kazuhiko;
Uchida, Kazumi;
Nakajima, Go;
Hatori, Takashi;
Danenberg, Kathleen;
Danenberg, Peter V.;
Yamamoto, Masakazu

Publication type:

Article

A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 631, doi. 10.1007/s00280-007-0516-6

By:

Lee, Jae-Lyun;
Ryu, Min-Hee;
Chang, Heung;
Kim, Tae-Won;
Yook, Jeong;
Oh, Sung;
Kim, Byung;
Kim, Minsun;
Chun, Young;
Lee, Jung;
Kang, Yoon-Koo

Publication type:

Article

A late phase II study of S-1 for metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 615, doi. 10.1007/s00280-007-0514-8

By:

Okusaka, Takuji;
Funakoshi, Akihiro;
Furuse, Junji;
Boku, Narikazu;
Yamao, Kenji;
Ohkawa, Shinichi;
Saito, Hiroshi

Publication type:

Article

A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 689, doi. 10.1007/s00280-007-0524-6

By:

Stadler, Walter;
Desai, Apurva;
Quinn, David;
Bukowski, Ronald;
Poiesz, Bernard;
Kardinal, Carl;
Lewis, Nancy;
Makalinao, Alex;
Murray, Peter;
Torti, Frank

Publication type:

Article

Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 2, p. 335, doi. 10.1007/s00280-007-0595-4

By:

Yamanaka, Takeharu;
Matsumoto, Shigemi;
Teramukai, Satoshi;
Ishiwata, Ryota;
Nagai, Yoji;
Fukushima, Masanori

Publication type:

Article

Third-line therapy for metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 1, doi. 10.1007/s00280-007-0573-x

By:

Gundgaard, M. G.;
Soerensen, J. B.;
Ehrnrooth, E.

Publication type:

Article

Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 5, p. 693, doi. 10.1007/s00280-007-0415-x

By:

Kochi, Mitsugu;
Fujii, Masashi;
Kanamori, Noriaki;
Kaiga, Teruo;
Aizaki, Kazuo;
Takahashi, Toru;
Takayama, Tadatoshi

Publication type:

Article

Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 5, p. 733, doi. 10.1007/s00280-007-0419-6

By:

Pentheroudakis, G.;
Pappas, P.;
Golfinopoulos, V.;
Fountzilas, G.;
Nikolaidou, M.;
Boumba, V.;
Vougiouklakis, T.;
Nikiforidis, L.;
Tzamakou, E.;
Siarabi, O.;
Marselos, M.;
Pavlidis, N.

Publication type:

Article

DPYD*2A mutation: the most common mutation associated with DPD deficiency.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 4, p. 503, doi. 10.1007/s00280-006-0392-5

By:

Saif, M.;
Ezzeldin, Hany;
Vance, Katisha;
Sellers, Sandra;
Diasio, Robert

Publication type:

Article

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 4, p. 419, doi. 10.1007/s00280-005-0167-4

By:

Feliu, J.;
Sáenz, J. Garcí;
Jaráiz, A. Rodríguez;
Castañón, C.;
Cruz, M.;
Fonseca, E.;
Lomas, M.;
Castro, J.;
Jara, C.;
Casado, E.;
León, A.;
Barón, M. González

Publication type:

Article

Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 835, doi. 10.1007/s00280-005-0089-1

By:

Marcuello, E.;
Altés, A.;
Menoyo, A.;
del Rio, E.;
Baiget, M.

Publication type:

Article

The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 577, doi. 10.1007/s00280-005-0081-9

By:

Ogata, Yutaka;
Matono, Keiko;
Sasatomi, Teruo;
Ishibashi, Nobuya;
Ohkita, Akira;
Mizobe, Tomoaki;
Ogo, Shujiro;
Ikeda, Satoru;
Ozasa, Hiroyuki;
Shirouzu, Kazuo

Publication type:

Article

Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 6, p. 594, doi. 10.1007/s00280-005-1011-6

By:

Nikolic-Tomasevic, Z.;
Jelic, S.;
Cassidy, J.;
Filipovic-Ljeskovic, I.;
Tomasevic, Z.

Publication type:

Article

Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 465, doi. 10.1007/s00280-005-1018-z

By:

Yawata, Ayako;
Su-Ryang Kim;
Miyajima, Atsuko;
Kubo, Takashi;
Ishida, Seiichi;
Saito, Yoshiro;
Nakajima, Yukiko;
Katori, Noriko;
Matsumoto, Yoshiaki;
Fukuoka, Masamichi;
Ohno, Yasuo;
Ozawa, Shogo;
Sawada, Jun-ichi

Publication type:

Article

Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR).

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 2, p. 205, doi. 10.1007/s00280-004-0934-7

By:

Ebi, Hiromichi;
Sigeoka, Yasushi;
Saeki, Toshiaki;
Kawada, Kenji;
Igarashi, Tadahiko;
Usubuchi, Noriko;
Ueda, Ryuzo;
Sasaki, Yasutsuna;
Minami, Hironobu

Publication type:

Article

Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 531, doi. 10.1007/s00280-004-0802-5

By:

Tsuji, Takashi;
Sawai, Terumitsu;
Takeshita, Hiroaki;
Nakagoe, Tohru;
Hidaka, Shigekazu;
Yamaguchi, Hiroyuki;
Yasutake, Toru;
Nagayasu, Takeshi;
Tagawa, Yutaka

Publication type:

Article

Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 5, p. 409, doi. 10.1007/s00280-003-0732-7

By:

Patel, Aneeta;
Pluim, Thomas;
Helms, Amy;
Bauer, Andrew;
Tuttle, R. Michael;
Francis, Gary L.

Publication type:

Article

Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer.

Published in:

2003

By:

Yamada, Yasuhide;
Shirao, Kuniaki;
Hyodo, Ichinosuke;
Arai, Yasuaki;
Denda, Tadamichi;
Ambo, Tomonori;
Ohtsu, Atsushi

Publication type:

journal article

Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5′-dFUrd in human breast cancer models.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 3, p. 211, doi. 10.1007/s00280-001-0401-7

By:

Fujimoto-Ouchi, Kaori;
Sekiguchi, Fumiko;
Tanaka, Yutaka

Publication type:

Article

Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study.

Published in:

2001

By:

Porta, Camillo;
Danova, Marco;
Accurso, Salvatore;
Tinelli, Carmine;
Girino, Margherita;
Riccardi, Alberto;
Palmeri, Sergio;
Porta, C;
Danova, M;
Accurso, S;
Tinelli, C;
Girino, M;
Riccardi, A;
Palmeri, S

Publication type:

journal article

Stability of commercial solutions of 5-fluorouracil for continuous infusion in an ambulatory pump.

Published in:

Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 6, p. 501, doi. 10.1007/s002800000182

By:

Fournet, Alexandra;
Gilard, Véronique;
Malet-Martino, Myriam;
Martino, Robert;
Canal, Pierre;
De Forni, Marcel

Publication type:

Article

Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302).

Published in:

Oncology, 2011, v. 80, n. 1/2, p. 70, doi. 10.1159/000328739

By:

Komatsu, Yoshito;
Yuki, Satoshi;
Sogabe, Susumu;
Fukushima, Hiraku;
Iwanaga, Ichiro;
Kudo, Mineo;
Tateyama, Miki;
Meguro, Takashi;
Uebayashi, Minoru;
Saga, Akiyoshi;
Sakata, Yuh;
Asaka, Masahiro

Publication type:

Article

Long-Term Outcome of Combined Interferon-α and 5-Fluorouracil Treatment for Advanced Hepatocellular Carcinoma with Major Portal Vein Thrombosis.

Published in:

Oncology, 2011, v. 80, n. 1/2, p. 63, doi. 10.1159/000328281

By:

Nagano, Hiroaki;
Wada, Hiroshi;
Kobayashi, Shogo;
Marubashi, Shigeru;
Eguchi, Hidetoshi;
Tanemura, Masahiro;
Tomimaru, Yoshito;
Osuga, Keigo;
Umeshita, Koji;
Doki, Yuichiro;
Mori, Masaki

Publication type:

Article

Rechallenge with Platinum plus Fluoropyrimidine +/- Epirubicin in Patients with Oesophagogastric Cancer.

Published in:

Oncology, 2010, v. 79, n. 1/2, p. 150, doi. 10.1159/000322114

By:

Okines, A. F. C.;
Asghar, U.;
Cunningham, D.;
Ashley, S.;
Jackson, K.;
Hawkes, E.;
Chau, I.;
Ashton, J.

Publication type:

Article

Efficacy of S-1 in Patients with Castration-Resistant Prostate Cancer: A Phase II Study.

Published in:

Oncology, 2010, v. 78, n. 5/6, p. 323, doi. 10.1159/000319939

By:

Akaza, Hideyuki;
Ikemoto, Isao;
Namiki, Mikio;
Usami, Michiyuki;
Kobayashi, Mikio;
Fujimoto, Hiroyuki;
Tsukamoto, Taiji;
Naito, Seiji

Publication type:

Article

The Role of UFT in Metastatic Colorectal Cancer.

Published in:

Oncology, 2009, v. 76, n. 5, p. 301, doi. 10.1159/000209334

By:

Bennouna, Jaafar;
Saunders, Mark;
Douillard, Jean-Yves

Publication type:

Article

Cardiac Toxicity with Capecitabine, Vinorelbine and Trastuzumab Therapy: Case Report and Review of Fluoropyrimidine-Related Cardiotoxicity.

Published in:

Oncology, 2009, v. 76, n. 5, p. 322, doi. 10.1159/000209336

By:

Le Brun-Ly, Valérie;
Martin, Jean;
Venat-Bouvet, Laurence;
Darodes, Nicole;
Labourey, Jean-Luc;
Genet, Dominique;
Tubiana-Mathieu, Nicole

Publication type:

Article

Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer.

Published in:

Oncology, 2009, v. 76, n. 3, p. 151, doi. 10.1159/000195884

By:

Arkenau, Hendrik-Tobias;
Brunetto, Andre T.;
Barriuso, Jorge;
Olmos, David;
Eaton, David;
De Bono, Johann;
Judson, Ian;
Kaye, Stan

Publication type:

Article

Combination Therapy of Oral Fluoropyrimidine Anticancer Drug S-1 and Interferon Alpha for HCC Patients with Extrahepatic Metastases.

Published in:

Oncology, 2008, v. 75, n. 1/2, p. 8, doi. 10.1159/000151614

By:

Uka, Kiminori;
Aikata, Hiroshi;
Mori, Nami;
Takaki, Shintaro;
Kawakami, Yoshiiku;
Azakami, Takahiro;
Kawaoka, Tomokazu;
Soo Cheol Jeong;
Takahashi, Shoichi;
Chayama, Kazuaki

Publication type:

Article

Single Nucleotide Polymorphisms in Nucleotide Excision Repair Genes XPA, XPD, XPG and ERCC1 in Advanced Colorectal Cancer Patients Treated with First-Line Oxaliplatin/Fluoropyrimidine.

Published in:

Oncology, 2007, v. 72, n. 5/6, p. 364, doi. 10.1159/000113534

By:

Monzo, Mariano;
Moreno, Isabel;
Navarro, Alfons;
Ibeas, Rafael;
Artells, Rosa;
Gel, Bernat;
Martinez, Francisco;
Moreno, Jose;
Hernandez, Raquel;
Navarro-Vigo, Marta

Publication type:

Article

An Open-Label, Multicenter Study of Outpatient Capecitabine Monotherapy in 631 Patients with Pretreated Advanced Breast Cancer.

Published in:

Oncology, 2007, v. 72, n. 1/2, p. 51, doi. 10.1159/000111094

By:

Venturini, M.;
Paridaens, R.;
Rossner, D.;
Vaslamatzis, M. M.;
Nortier, J. W. R.;
Salzberg, M.;
Rodrigues, H.;
Bell, R.

Publication type:

Article

Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling Studies.

Published in:

Oncology, 2007, v. 72, n. 1/2, p. 118, doi. 10.1159/000111130

By:

Passardi, A.;
Maltoni, R.;
Milandri, C.;
Cecconetto, L.;
Massa, I.;
Zoli, W.;
Tesei, A.;
Fabbri, F.;
Nanni, O.;
Amadori, D.

Publication type:

Article

Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer.

Published in:

Oncology, 2006, v. 70, n. 3, p. 222, doi. 10.1159/000094357

By:

Ducreux, M.;
Bouche, O.;
Pignon, J. P.;
Mousseau, M.;
Raoul, J. L.;
Cassan, P.;
Leduc, B.;
Berger, C.;
Dunant, A.;
Fournet, J.;
Bedenne, L.

Publication type:

Article

Expression of the High-Affinity Fluoropyrimidine-Preferring Nucleoside Transporter hCNT1 Correlates with Decreased Disease-Free Survival in Breast Cancer.

Published in:

Oncology, 2006, v. 70, n. 3, p. 238, doi. 10.1159/000094541

By:

Gloeckner-Hofmann, Katharina;
Guillén-Gómez, Elena;
Schmidtgen, Claudia;
Porstmann, Romy;
Ziegler, Ralf;
Stoss, Oliver;
Casado, F. Javier;
Rüschoff, Josef;
Pastor-Anglada, Marçal

Publication type:

Article